Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Grows By 25.6%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 5,400 shares, a growth of 25.6% from the November 30th total of 4,300 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Laboratorios Farmaceuticos Rovi stock remained flat at C$65.86 during trading on Friday. The stock has a 50 day simple moving average of C$78.73 and a 200 day simple moving average of C$86.01. Laboratorios Farmaceuticos Rovi has a 1-year low of C$65.86 and a 1-year high of C$65.86.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.